Dr. Berg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
450 Brookline Ave
Boston, MA 02215- Is this information wrong?
Education & Training
- Loyola University Medical CenterFellowship, Hematology and Medical Oncology, 2015 - 2018
- University of Illinois College of Medicine at ChicagoChief Residency, Internal Medicine, 2014 - 2015
- University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 2011 - 2014
- Lake Erie College of Osteopathic Medicine Bradenton CampusClass of 2011
- University of MiamiBS, Biology, 2001 - 2005
Certifications & Licensure
- IL State License 2011 - 2026
- MA State License 2022 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- ACLS ACLS
Clinical Trials
- Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study Start of enrollment: 2019 Jun 07
- Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors Start of enrollment: 2019 May 13
- Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects Start of enrollment: 2020 Jan 31
- Join now to see all
Publications & Presentations
PubMed
- Understanding Adjuvant Therapy for Upper Tract Urothelial Carcinoma.Berg, S., Galsky, M.> ;Journal of Clinical Oncology. 2024 Feb 15
- One Size Fits Some: Approaching Rare Malignancies of the Urinary Tract.Berg, S., McGregor, B.> ;Current Treatment Options in Oncology. 2024 Feb 1
- Mutual ATRaction: Assessing Synergy of Berzosertib with Sacituzumab Govitecan.Stephanie A Berg, Atish D Choudhury> ;Clinical Cancer Research. 2023 Sep 15
- Join now to see all
Press Mentions
- Study Shows Structural Racism Can Result in Poorer Leukemia OutcomesMarch 7th, 2022
- DCVAC/PCa Use Alongside Chemotherapy Shows No Additional mCRPC Survival BenefitFebruary 28th, 2022
- Active Cellular Immunotherapy Disappoints in Metastatic Prostate CancerFebruary 10th, 2022
Committees
- Executives Officer, Experimental Therapeutics and Rare Tumors, Alliance for Clinical Trials in Oncology 2021 - Present
Professional Memberships
- Member
- Fellow
- Member
Hospital Affiliations
- Dana-Farber Cancer InstituteBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: